Biogen’s higher Spinraza dose shows better efficacy in Phase II/III trial
A trial studying a higher dose of Biogen’s spinal muscular atrophy (SMA) drug Spinraza (nusinersen) has met the primary endpoint …
Post
-
-
Plan for success and prepare for adversity – Clinical Trial Supply West Coast 2024
The 17th Annual Clinical Trial Supply West Coast 2024 conference in San Francisco will bring together regional industry leaders and …
-
GSK’s asthma blockbuster Nucala secures win in COPD Phase III trial
GSK’s asthma drug Nucala (mepolizumab) has met the primary endpoint in a Phase III trial treating patients with chronic obstructive …
-
Tempo doses first patient with tissue scaffolds in cancer surgery trial
Tempo Therapeutics has started the first in-human trial for its tissue regeneration product, TT101, in patients who have undergone surgical …
-
Rigel enrols first participant in Phase Ib/II AML treatment regimen trial
Rigel Pharmaceuticals has announced the enrolment of the first subject in a Phase Ib/II clinical trial of REZLIDHIA (olutasidenib) in …
-
Aurinia doses first subject in Phase Ia trial of AUR200 for autoimmune diseases
Aurinia Pharmaceuticals has dosed the first subject in a Phase Ia single ascending dose (SAD) clinical trial of AUR200, as …
-
Community research 101: Everything you need to know about mobile visits and community sites
DCTs seek to reduce the number of visits a participant is required to make to a clinical trial site – …
-
Boehringer and CDR-Life report data from geographic atrophy treatment trial
Boehringer Ingelheim and CDR-Life have reported positive outcomes from the Phase I clinical trial of BI 771716, a new treatment …
-
Lilly’s efsitora shows promise in Phase III type 2 diabetes trials
Eli Lilly and Company has revealed positive topline results from the Phase III clinical trials of once-weekly insulin efsitora alfa …
-
Migraine market expected to reach $16.4bn across 7MM by 2033
The migraine market across the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) is poised to …
-
As mpox spreads, ‘national governments have a moral responsibility to help’
As the number of mpox-related deaths in the Democratic Republic of Congo (DRC) and neighbouring countries continues to climb, international …
-
Moderna mpox mRNA vaccine shows early promise in monkey study
Moderna has announced its mRNA vaccine in development for mpox is more effective than Bavarian Nordics Jynneos in prevention of …
-
Allurion’s swallowable balloon leads to 13% weight reduction in teens
Amid the hype of weight loss pills, Allurion is pushing ahead with its swallowable balloon – with the company reporting …
-
Mpox declared public health emergency in Africa
On Wednesday 13 August, the Africa Centres for Disease Control and Prevention (Africa CDC) stated the current mpox outbreak to …
-
IN8bio cuts staff and pipeline to focus on AML cell therapy
IN8bio, formerly Incysus Therapeutics, has instituted cash-saving measures to funnel resources into advancing its acute myeloid leukaemia (AML) allogenic cell …
